宁光教授获2014年AACE国际内分泌学大奖

2014-06-03 中华医学会内分泌学分会网站 中国医学论坛报糖尿病手机报

近日,在美国拉斯维加斯召开的美国临床内分泌医师学会第23届科学年会(AACE2014)上,我国宁光教授荣获国际内分泌学大奖(The International Endocrinology Award)。 宁光教授是中国医师协会内分泌代谢科医师分会会长,AACE历来重视与中国的学术交流,此次特邀宁光教授参加本次会议,并授予其国际内分泌学大奖,以表彰其多年来为中国和美国双方的内分泌代谢医师学术交

近日,在美国拉斯维加斯召开的美国临床内分泌医师学会第23届科学年会(AACE2014)上,我国宁光教授荣获国际内分泌学大奖(The International Endocrinology Award)。

宁光教授是中国医师协会内分泌代谢科医师分会会长,AACE历来重视与中国的学术交流,此次特邀宁光教授参加本次会议,并授予其国际内分泌学大奖,以表彰其多年来为中国和美国双方的内分泌代谢医师学术交流做出的贡献。

宁光教授表示,“非常荣幸能够获得AACE颁发的这一奖项,这是对中国内分泌领域进展的认可,我和同事们会更积极努力在世界内分泌平台上展示中国成果”。宁光教授还介绍了我们多年来在中美内分泌代谢病学术交流方面做出的努力以及中国近年来在内分泌代谢病临床研究方面的进展,希望双方能有进一步更深层次的合作和交流。

AACE的多名教授应宁光教授的邀请,将参加于2014年7月10日~13日在中国福建厦门举行的2014年中国医师协会内分泌代谢科医师分会年会。

美国临床内分泌医师学会(American Association of Clinical Endocrinologists,简称AACE)是美国从事内分泌代谢病专业临床医师的学术组织,每年的美国临床内分泌医师年会为国际上从事内分泌代谢的临床医师提供了很好的学术交流平台,每年均有一系列临床指南和专家共识在此年会上发布,为临床提供诊断和治疗的参考。

国际内分泌学大奖被授予美国以外的内分泌专家,是为表彰他们对内分泌疾病患者的卓越管理、对内分泌疾病人群的管理、建立内分泌疾病管理系统、组织临床内分泌专家、带来了改进内分泌患者管理的社会变革以及开展内分泌疾病公众教育。







图片来自徐焰(中国医师协会内分泌代谢科医师分会秘书)微信


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1699183, encodeId=f97c16991832f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Sun Dec 14 02:30:00 CST 2014, time=2014-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655700, encodeId=80951655e0024, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jan 13 14:30:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649148, encodeId=b10f164914856, content=<a href='/topic/show?id=2468456550a' target=_blank style='color:#2F92EE;'>#宁光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45655, encryptionId=2468456550a, topicName=宁光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f23763610, createdName=zhmscau, createdTime=Mon Oct 06 08:30:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682178, encodeId=b83516821e890, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Mon Sep 22 07:30:00 CST 2014, time=2014-09-22, status=1, ipAttribution=)]
    2014-12-14 zgwhgch
  2. [GetPortalCommentsPageByObjectIdResponse(id=1699183, encodeId=f97c16991832f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Sun Dec 14 02:30:00 CST 2014, time=2014-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655700, encodeId=80951655e0024, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jan 13 14:30:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649148, encodeId=b10f164914856, content=<a href='/topic/show?id=2468456550a' target=_blank style='color:#2F92EE;'>#宁光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45655, encryptionId=2468456550a, topicName=宁光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f23763610, createdName=zhmscau, createdTime=Mon Oct 06 08:30:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682178, encodeId=b83516821e890, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Mon Sep 22 07:30:00 CST 2014, time=2014-09-22, status=1, ipAttribution=)]
    2015-01-13 shanyongle
  3. [GetPortalCommentsPageByObjectIdResponse(id=1699183, encodeId=f97c16991832f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Sun Dec 14 02:30:00 CST 2014, time=2014-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655700, encodeId=80951655e0024, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jan 13 14:30:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649148, encodeId=b10f164914856, content=<a href='/topic/show?id=2468456550a' target=_blank style='color:#2F92EE;'>#宁光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45655, encryptionId=2468456550a, topicName=宁光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f23763610, createdName=zhmscau, createdTime=Mon Oct 06 08:30:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682178, encodeId=b83516821e890, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Mon Sep 22 07:30:00 CST 2014, time=2014-09-22, status=1, ipAttribution=)]
    2014-10-06 zhmscau
  4. [GetPortalCommentsPageByObjectIdResponse(id=1699183, encodeId=f97c16991832f, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Sun Dec 14 02:30:00 CST 2014, time=2014-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655700, encodeId=80951655e0024, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Jan 13 14:30:00 CST 2015, time=2015-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649148, encodeId=b10f164914856, content=<a href='/topic/show?id=2468456550a' target=_blank style='color:#2F92EE;'>#宁光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45655, encryptionId=2468456550a, topicName=宁光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb4f23763610, createdName=zhmscau, createdTime=Mon Oct 06 08:30:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682178, encodeId=b83516821e890, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Mon Sep 22 07:30:00 CST 2014, time=2014-09-22, status=1, ipAttribution=)]
    2014-09-22 gwc392